Standard BioTools Inc.
LAB
$0.90
-$0.06-6.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.80M | 19.55M | 21.76M | 20.22M | 24.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.80M | 19.55M | 21.76M | 20.22M | 24.78M |
| Cost of Revenue | 12.41M | 10.07M | 16.88M | 14.27M | 13.42M |
| Gross Profit | 11.38M | 9.48M | 4.89M | 5.95M | 11.36M |
| SG&A Expenses | 25.34M | 26.60M | 28.11M | 29.82M | 27.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.72M | 43.02M | 45.46M | 44.44M | 47.78M |
| Operating Income | -21.92M | -23.47M | -23.70M | -24.22M | -23.00M |
| Income Before Tax | -22.03M | -32.90M | -18.28M | -23.49M | -26.90M |
| Income Tax Expenses | -35.93M | -1.22M | -609.00K | -119.00K | 272.00K |
| Earnings from Continuing Operations | 13.90M | -31.68M | -17.67M | -23.37M | -27.17M |
| Earnings from Discontinued Operations | 5.38M | -3.00M | -15.79M | -2.66M | -6.90M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.28M | -34.69M | -33.46M | -26.03M | -34.07M |
| EBIT | -21.92M | -23.47M | -23.70M | -24.22M | -23.00M |
| EBITDA | -16.64M | -21.87M | -19.71M | -20.04M | -10.51M |
| EPS Basic | 0.05 | -0.09 | -0.09 | -0.07 | -0.09 |
| Normalized Basic EPS | -0.02 | -0.04 | -0.03 | -0.04 | -0.04 |
| EPS Diluted | 0.05 | -0.09 | -0.09 | -0.07 | -0.09 |
| Normalized Diluted EPS | -0.02 | -0.04 | -0.03 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 385.05M | 382.63M | 380.50M | 378.24M | 374.54M |
| Average Diluted Shares Outstanding | 385.05M | 382.63M | 380.50M | 378.24M | 374.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |